Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPA-Copper IUS for Bleeding Control
NCT03230539Phase 1Unknown
- Sponsor
- Population Council
- Start
- May 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ulipristal in contraception (3 arms), sponsored by Population Council. Primary endpoint: Ability of the three doses of UPA as delivered by IUS to suppress bleeding at 12 weeks. Status: unknown.
02
Drugs
ulipristal
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03230539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03230539.